Global Veterinary Biological Vaccines Market Research Report 2024
Report Overview:
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
The Global Veterinary Biological Vaccines Market Size was estimated at USD 5178.07 million in 2023 and is projected to reach USD 7303.71 million by 2029, exhibiting a CAGR of 5.90% during the forecast period.
This report provides a deep insight into the global Veterinary Biological Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Veterinary Biological Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Veterinary Biological Vaccines market in any manner.
Global Veterinary Biological Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Yebio
DHN
WINSUN
Elanco
Virbac
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
Ringpu Biology
Jinyu Bio-technology
Jinhe Biotechnology
China Animal Husbandry Industry
Wuhan Keqian Biology
Pulike Biological Engineering
Chengdu Kanghua Biological Products
Market Segmentation (by Type)
Live Attenuated Vaccines
Inactivated Vaccines
Others
Market Segmentation (by Application)
Livestock
Swine
Chicken
Others
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Veterinary Biological Vaccines Market
• Overview of the regional outlook of the Veterinary Biological Vaccines Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Veterinary Biological Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Markets Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
The Global Veterinary Biological Vaccines Market Size was estimated at USD 5178.07 million in 2023 and is projected to reach USD 7303.71 million by 2029, exhibiting a CAGR of 5.90% during the forecast period.
This report provides a deep insight into the global Veterinary Biological Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Veterinary Biological Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Veterinary Biological Vaccines market in any manner.
Global Veterinary Biological Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Yebio
DHN
WINSUN
Elanco
Virbac
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
Ringpu Biology
Jinyu Bio-technology
Jinhe Biotechnology
China Animal Husbandry Industry
Wuhan Keqian Biology
Pulike Biological Engineering
Chengdu Kanghua Biological Products
Market Segmentation (by Type)
Live Attenuated Vaccines
Inactivated Vaccines
Others
Market Segmentation (by Application)
Livestock
Swine
Chicken
Others
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Veterinary Biological Vaccines Market
• Overview of the regional outlook of the Veterinary Biological Vaccines Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Veterinary Biological Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Markets Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Veterinary Biological Vaccines
1.2 Key Market Segments
1.2.1 Veterinary Biological Vaccines Segment by Type
1.2.2 Veterinary Biological Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Veterinary Biological Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Veterinary Biological Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Veterinary Biological Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Veterinary Biological Vaccines Market Competitive Landscape
3.1 Global Veterinary Biological Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Veterinary Biological Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Veterinary Biological Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Veterinary Biological Vaccines Sales Sites, Area Served, Product Type
3.6 Veterinary Biological Vaccines Market Competitive Situation and Trends
3.6.1 Veterinary Biological Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Veterinary Biological Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Veterinary Biological Vaccines Industry Chain Analysis
4.1 Veterinary Biological Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Veterinary Biological Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Veterinary Biological Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Veterinary Biological Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Veterinary Biological Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Veterinary Biological Vaccines Price by Type (2019-2024)
7 Veterinary Biological Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Veterinary Biological Vaccines Market Sales by Application (2019-2024)
7.3 Global Veterinary Biological Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Veterinary Biological Vaccines Sales Growth Rate by Application (2019-2024)
8 Veterinary Biological Vaccines Market Segmentation by Region
8.1 Global Veterinary Biological Vaccines Sales by Region
8.1.1 Global Veterinary Biological Vaccines Sales by Region
8.1.2 Global Veterinary Biological Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Veterinary Biological Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Veterinary Biological Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Veterinary Biological Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Veterinary Biological Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Veterinary Biological Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Veterinary Biological Vaccines Basic Information
9.1.2 Merck Veterinary Biological Vaccines Product Overview
9.1.3 Merck Veterinary Biological Vaccines Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Veterinary Biological Vaccines SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Zoetis
9.2.1 Zoetis Veterinary Biological Vaccines Basic Information
9.2.2 Zoetis Veterinary Biological Vaccines Product Overview
9.2.3 Zoetis Veterinary Biological Vaccines Product Market Performance
9.2.4 Zoetis Business Overview
9.2.5 Zoetis Veterinary Biological Vaccines SWOT Analysis
9.2.6 Zoetis Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Veterinary Biological Vaccines Basic Information
9.3.2 Boehringer Ingelheim Veterinary Biological Vaccines Product Overview
9.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Product Market Performance
9.3.4 Boehringer Ingelheim Veterinary Biological Vaccines SWOT Analysis
9.3.5 Boehringer Ingelheim Business Overview
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Ceva
9.4.1 Ceva Veterinary Biological Vaccines Basic Information
9.4.2 Ceva Veterinary Biological Vaccines Product Overview
9.4.3 Ceva Veterinary Biological Vaccines Product Market Performance
9.4.4 Ceva Business Overview
9.4.5 Ceva Recent Developments
9.5 CAHIC
9.5.1 CAHIC Veterinary Biological Vaccines Basic Information
9.5.2 CAHIC Veterinary Biological Vaccines Product Overview
9.5.3 CAHIC Veterinary Biological Vaccines Product Market Performance
9.5.4 CAHIC Business Overview
9.5.5 CAHIC Recent Developments
9.6 HVRI
9.6.1 HVRI Veterinary Biological Vaccines Basic Information
9.6.2 HVRI Veterinary Biological Vaccines Product Overview
9.6.3 HVRI Veterinary Biological Vaccines Product Market Performance
9.6.4 HVRI Business Overview
9.6.5 HVRI Recent Developments
9.7 Yebio
9.7.1 Yebio Veterinary Biological Vaccines Basic Information
9.7.2 Yebio Veterinary Biological Vaccines Product Overview
9.7.3 Yebio Veterinary Biological Vaccines Product Market Performance
9.7.4 Yebio Business Overview
9.7.5 Yebio Recent Developments
9.8 DHN
9.8.1 DHN Veterinary Biological Vaccines Basic Information
9.8.2 DHN Veterinary Biological Vaccines Product Overview
9.8.3 DHN Veterinary Biological Vaccines Product Market Performance
9.8.4 DHN Business Overview
9.8.5 DHN Recent Developments
9.9 WINSUN
9.9.1 WINSUN Veterinary Biological Vaccines Basic Information
9.9.2 WINSUN Veterinary Biological Vaccines Product Overview
9.9.3 WINSUN Veterinary Biological Vaccines Product Market Performance
9.9.4 WINSUN Business Overview
9.9.5 WINSUN Recent Developments
9.10 Elanco
9.10.1 Elanco Veterinary Biological Vaccines Basic Information
9.10.2 Elanco Veterinary Biological Vaccines Product Overview
9.10.3 Elanco Veterinary Biological Vaccines Product Market Performance
9.10.4 Elanco Business Overview
9.10.5 Elanco Recent Developments
9.11 Virbac
9.11.1 Virbac Veterinary Biological Vaccines Basic Information
9.11.2 Virbac Veterinary Biological Vaccines Product Overview
9.11.3 Virbac Veterinary Biological Vaccines Product Market Performance
9.11.4 Virbac Business Overview
9.11.5 Virbac Recent Developments
9.12 CAVAC
9.12.1 CAVAC Veterinary Biological Vaccines Basic Information
9.12.2 CAVAC Veterinary Biological Vaccines Product Overview
9.12.3 CAVAC Veterinary Biological Vaccines Product Market Performance
9.12.4 CAVAC Business Overview
9.12.5 CAVAC Recent Developments
9.13 Kyoto Biken Laboratories
9.13.1 Kyoto Biken Laboratories Veterinary Biological Vaccines Basic Information
9.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Overview
9.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Market Performance
9.13.4 Kyoto Biken Laboratories Business Overview
9.13.5 Kyoto Biken Laboratories Recent Developments
9.14 FATRO
9.14.1 FATRO Veterinary Biological Vaccines Basic Information
9.14.2 FATRO Veterinary Biological Vaccines Product Overview
9.14.3 FATRO Veterinary Biological Vaccines Product Market Performance
9.14.4 FATRO Business Overview
9.14.5 FATRO Recent Developments
9.15 Vaksindo
9.15.1 Vaksindo Veterinary Biological Vaccines Basic Information
9.15.2 Vaksindo Veterinary Biological Vaccines Product Overview
9.15.3 Vaksindo Veterinary Biological Vaccines Product Market Performance
9.15.4 Vaksindo Business Overview
9.15.5 Vaksindo Recent Developments
9.16 Bio-Labs
9.16.1 Bio-Labs Veterinary Biological Vaccines Basic Information
9.16.2 Bio-Labs Veterinary Biological Vaccines Product Overview
9.16.3 Bio-Labs Veterinary Biological Vaccines Product Market Performance
9.16.4 Bio-Labs Business Overview
9.16.5 Bio-Labs Recent Developments
9.17 Avimex Animal Health
9.17.1 Avimex Animal Health Veterinary Biological Vaccines Basic Information
9.17.2 Avimex Animal Health Veterinary Biological Vaccines Product Overview
9.17.3 Avimex Animal Health Veterinary Biological Vaccines Product Market Performance
9.17.4 Avimex Animal Health Business Overview
9.17.5 Avimex Animal Health Recent Developments
9.18 MEVAC
9.18.1 MEVAC Veterinary Biological Vaccines Basic Information
9.18.2 MEVAC Veterinary Biological Vaccines Product Overview
9.18.3 MEVAC Veterinary Biological Vaccines Product Market Performance
9.18.4 MEVAC Business Overview
9.18.5 MEVAC Recent Developments
9.19 Biovac
9.19.1 Biovac Veterinary Biological Vaccines Basic Information
9.19.2 Biovac Veterinary Biological Vaccines Product Overview
9.19.3 Biovac Veterinary Biological Vaccines Product Market Performance
9.19.4 Biovac Business Overview
9.19.5 Biovac Recent Developments
9.20 Atafen
9.20.1 Atafen Veterinary Biological Vaccines Basic Information
9.20.2 Atafen Veterinary Biological Vaccines Product Overview
9.20.3 Atafen Veterinary Biological Vaccines Product Market Performance
9.20.4 Atafen Business Overview
9.20.5 Atafen Recent Developments
9.21 Dyntec
9.21.1 Dyntec Veterinary Biological Vaccines Basic Information
9.21.2 Dyntec Veterinary Biological Vaccines Product Overview
9.21.3 Dyntec Veterinary Biological Vaccines Product Market Performance
9.21.4 Dyntec Business Overview
9.21.5 Dyntec Recent Developments
9.22 Ringpu Biology
9.22.1 Ringpu Biology Veterinary Biological Vaccines Basic Information
9.22.2 Ringpu Biology Veterinary Biological Vaccines Product Overview
9.22.3 Ringpu Biology Veterinary Biological Vaccines Product Market Performance
9.22.4 Ringpu Biology Business Overview
9.22.5 Ringpu Biology Recent Developments
9.23 Jinyu Bio-technology
9.23.1 Jinyu Bio-technology Veterinary Biological Vaccines Basic Information
9.23.2 Jinyu Bio-technology Veterinary Biological Vaccines Product Overview
9.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Product Market Performance
9.23.4 Jinyu Bio-technology Business Overview
9.23.5 Jinyu Bio-technology Recent Developments
9.24 Jinhe Biotechnology
9.24.1 Jinhe Biotechnology Veterinary Biological Vaccines Basic Information
9.24.2 Jinhe Biotechnology Veterinary Biological Vaccines Product Overview
9.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Product Market Performance
9.24.4 Jinhe Biotechnology Business Overview
9.24.5 Jinhe Biotechnology Recent Developments
9.25 China Animal Husbandry Industry
9.25.1 China Animal Husbandry Industry Veterinary Biological Vaccines Basic Information
9.25.2 China Animal Husbandry Industry Veterinary Biological Vaccines Product Overview
9.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Product Market Performance
9.25.4 China Animal Husbandry Industry Business Overview
9.25.5 China Animal Husbandry Industry Recent Developments
9.26 Wuhan Keqian Biology
9.26.1 Wuhan Keqian Biology Veterinary Biological Vaccines Basic Information
9.26.2 Wuhan Keqian Biology Veterinary Biological Vaccines Product Overview
9.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Product Market Performance
9.26.4 Wuhan Keqian Biology Business Overview
9.26.5 Wuhan Keqian Biology Recent Developments
9.27 Pulike Biological Engineering
9.27.1 Pulike Biological Engineering Veterinary Biological Vaccines Basic Information
9.27.2 Pulike Biological Engineering Veterinary Biological Vaccines Product Overview
9.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Product Market Performance
9.27.4 Pulike Biological Engineering Business Overview
9.27.5 Pulike Biological Engineering Recent Developments
9.28 Chengdu Kanghua Biological Products
9.28.1 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Basic Information
9.28.2 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Overview
9.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Market Performance
9.28.4 Chengdu Kanghua Biological Products Business Overview
9.28.5 Chengdu Kanghua Biological Products Recent Developments
10 Veterinary Biological Vaccines Market Forecast by Region
10.1 Global Veterinary Biological Vaccines Market Size Forecast
10.2 Global Veterinary Biological Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Veterinary Biological Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Veterinary Biological Vaccines Market Size Forecast by Region
10.2.4 South America Veterinary Biological Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Veterinary Biological Vaccines by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Veterinary Biological Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Veterinary Biological Vaccines by Type (2025-2030)
11.1.2 Global Veterinary Biological Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Veterinary Biological Vaccines by Type (2025-2030)
11.2 Global Veterinary Biological Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Veterinary Biological Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Veterinary Biological Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Veterinary Biological Vaccines
1.2 Key Market Segments
1.2.1 Veterinary Biological Vaccines Segment by Type
1.2.2 Veterinary Biological Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Veterinary Biological Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Veterinary Biological Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Veterinary Biological Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Veterinary Biological Vaccines Market Competitive Landscape
3.1 Global Veterinary Biological Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Veterinary Biological Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Veterinary Biological Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Veterinary Biological Vaccines Sales Sites, Area Served, Product Type
3.6 Veterinary Biological Vaccines Market Competitive Situation and Trends
3.6.1 Veterinary Biological Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Veterinary Biological Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Veterinary Biological Vaccines Industry Chain Analysis
4.1 Veterinary Biological Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Veterinary Biological Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Veterinary Biological Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Veterinary Biological Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Veterinary Biological Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Veterinary Biological Vaccines Price by Type (2019-2024)
7 Veterinary Biological Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Veterinary Biological Vaccines Market Sales by Application (2019-2024)
7.3 Global Veterinary Biological Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Veterinary Biological Vaccines Sales Growth Rate by Application (2019-2024)
8 Veterinary Biological Vaccines Market Segmentation by Region
8.1 Global Veterinary Biological Vaccines Sales by Region
8.1.1 Global Veterinary Biological Vaccines Sales by Region
8.1.2 Global Veterinary Biological Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Veterinary Biological Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Veterinary Biological Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Veterinary Biological Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Veterinary Biological Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Veterinary Biological Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Veterinary Biological Vaccines Basic Information
9.1.2 Merck Veterinary Biological Vaccines Product Overview
9.1.3 Merck Veterinary Biological Vaccines Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Veterinary Biological Vaccines SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Zoetis
9.2.1 Zoetis Veterinary Biological Vaccines Basic Information
9.2.2 Zoetis Veterinary Biological Vaccines Product Overview
9.2.3 Zoetis Veterinary Biological Vaccines Product Market Performance
9.2.4 Zoetis Business Overview
9.2.5 Zoetis Veterinary Biological Vaccines SWOT Analysis
9.2.6 Zoetis Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Veterinary Biological Vaccines Basic Information
9.3.2 Boehringer Ingelheim Veterinary Biological Vaccines Product Overview
9.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Product Market Performance
9.3.4 Boehringer Ingelheim Veterinary Biological Vaccines SWOT Analysis
9.3.5 Boehringer Ingelheim Business Overview
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Ceva
9.4.1 Ceva Veterinary Biological Vaccines Basic Information
9.4.2 Ceva Veterinary Biological Vaccines Product Overview
9.4.3 Ceva Veterinary Biological Vaccines Product Market Performance
9.4.4 Ceva Business Overview
9.4.5 Ceva Recent Developments
9.5 CAHIC
9.5.1 CAHIC Veterinary Biological Vaccines Basic Information
9.5.2 CAHIC Veterinary Biological Vaccines Product Overview
9.5.3 CAHIC Veterinary Biological Vaccines Product Market Performance
9.5.4 CAHIC Business Overview
9.5.5 CAHIC Recent Developments
9.6 HVRI
9.6.1 HVRI Veterinary Biological Vaccines Basic Information
9.6.2 HVRI Veterinary Biological Vaccines Product Overview
9.6.3 HVRI Veterinary Biological Vaccines Product Market Performance
9.6.4 HVRI Business Overview
9.6.5 HVRI Recent Developments
9.7 Yebio
9.7.1 Yebio Veterinary Biological Vaccines Basic Information
9.7.2 Yebio Veterinary Biological Vaccines Product Overview
9.7.3 Yebio Veterinary Biological Vaccines Product Market Performance
9.7.4 Yebio Business Overview
9.7.5 Yebio Recent Developments
9.8 DHN
9.8.1 DHN Veterinary Biological Vaccines Basic Information
9.8.2 DHN Veterinary Biological Vaccines Product Overview
9.8.3 DHN Veterinary Biological Vaccines Product Market Performance
9.8.4 DHN Business Overview
9.8.5 DHN Recent Developments
9.9 WINSUN
9.9.1 WINSUN Veterinary Biological Vaccines Basic Information
9.9.2 WINSUN Veterinary Biological Vaccines Product Overview
9.9.3 WINSUN Veterinary Biological Vaccines Product Market Performance
9.9.4 WINSUN Business Overview
9.9.5 WINSUN Recent Developments
9.10 Elanco
9.10.1 Elanco Veterinary Biological Vaccines Basic Information
9.10.2 Elanco Veterinary Biological Vaccines Product Overview
9.10.3 Elanco Veterinary Biological Vaccines Product Market Performance
9.10.4 Elanco Business Overview
9.10.5 Elanco Recent Developments
9.11 Virbac
9.11.1 Virbac Veterinary Biological Vaccines Basic Information
9.11.2 Virbac Veterinary Biological Vaccines Product Overview
9.11.3 Virbac Veterinary Biological Vaccines Product Market Performance
9.11.4 Virbac Business Overview
9.11.5 Virbac Recent Developments
9.12 CAVAC
9.12.1 CAVAC Veterinary Biological Vaccines Basic Information
9.12.2 CAVAC Veterinary Biological Vaccines Product Overview
9.12.3 CAVAC Veterinary Biological Vaccines Product Market Performance
9.12.4 CAVAC Business Overview
9.12.5 CAVAC Recent Developments
9.13 Kyoto Biken Laboratories
9.13.1 Kyoto Biken Laboratories Veterinary Biological Vaccines Basic Information
9.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Overview
9.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Market Performance
9.13.4 Kyoto Biken Laboratories Business Overview
9.13.5 Kyoto Biken Laboratories Recent Developments
9.14 FATRO
9.14.1 FATRO Veterinary Biological Vaccines Basic Information
9.14.2 FATRO Veterinary Biological Vaccines Product Overview
9.14.3 FATRO Veterinary Biological Vaccines Product Market Performance
9.14.4 FATRO Business Overview
9.14.5 FATRO Recent Developments
9.15 Vaksindo
9.15.1 Vaksindo Veterinary Biological Vaccines Basic Information
9.15.2 Vaksindo Veterinary Biological Vaccines Product Overview
9.15.3 Vaksindo Veterinary Biological Vaccines Product Market Performance
9.15.4 Vaksindo Business Overview
9.15.5 Vaksindo Recent Developments
9.16 Bio-Labs
9.16.1 Bio-Labs Veterinary Biological Vaccines Basic Information
9.16.2 Bio-Labs Veterinary Biological Vaccines Product Overview
9.16.3 Bio-Labs Veterinary Biological Vaccines Product Market Performance
9.16.4 Bio-Labs Business Overview
9.16.5 Bio-Labs Recent Developments
9.17 Avimex Animal Health
9.17.1 Avimex Animal Health Veterinary Biological Vaccines Basic Information
9.17.2 Avimex Animal Health Veterinary Biological Vaccines Product Overview
9.17.3 Avimex Animal Health Veterinary Biological Vaccines Product Market Performance
9.17.4 Avimex Animal Health Business Overview
9.17.5 Avimex Animal Health Recent Developments
9.18 MEVAC
9.18.1 MEVAC Veterinary Biological Vaccines Basic Information
9.18.2 MEVAC Veterinary Biological Vaccines Product Overview
9.18.3 MEVAC Veterinary Biological Vaccines Product Market Performance
9.18.4 MEVAC Business Overview
9.18.5 MEVAC Recent Developments
9.19 Biovac
9.19.1 Biovac Veterinary Biological Vaccines Basic Information
9.19.2 Biovac Veterinary Biological Vaccines Product Overview
9.19.3 Biovac Veterinary Biological Vaccines Product Market Performance
9.19.4 Biovac Business Overview
9.19.5 Biovac Recent Developments
9.20 Atafen
9.20.1 Atafen Veterinary Biological Vaccines Basic Information
9.20.2 Atafen Veterinary Biological Vaccines Product Overview
9.20.3 Atafen Veterinary Biological Vaccines Product Market Performance
9.20.4 Atafen Business Overview
9.20.5 Atafen Recent Developments
9.21 Dyntec
9.21.1 Dyntec Veterinary Biological Vaccines Basic Information
9.21.2 Dyntec Veterinary Biological Vaccines Product Overview
9.21.3 Dyntec Veterinary Biological Vaccines Product Market Performance
9.21.4 Dyntec Business Overview
9.21.5 Dyntec Recent Developments
9.22 Ringpu Biology
9.22.1 Ringpu Biology Veterinary Biological Vaccines Basic Information
9.22.2 Ringpu Biology Veterinary Biological Vaccines Product Overview
9.22.3 Ringpu Biology Veterinary Biological Vaccines Product Market Performance
9.22.4 Ringpu Biology Business Overview
9.22.5 Ringpu Biology Recent Developments
9.23 Jinyu Bio-technology
9.23.1 Jinyu Bio-technology Veterinary Biological Vaccines Basic Information
9.23.2 Jinyu Bio-technology Veterinary Biological Vaccines Product Overview
9.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Product Market Performance
9.23.4 Jinyu Bio-technology Business Overview
9.23.5 Jinyu Bio-technology Recent Developments
9.24 Jinhe Biotechnology
9.24.1 Jinhe Biotechnology Veterinary Biological Vaccines Basic Information
9.24.2 Jinhe Biotechnology Veterinary Biological Vaccines Product Overview
9.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Product Market Performance
9.24.4 Jinhe Biotechnology Business Overview
9.24.5 Jinhe Biotechnology Recent Developments
9.25 China Animal Husbandry Industry
9.25.1 China Animal Husbandry Industry Veterinary Biological Vaccines Basic Information
9.25.2 China Animal Husbandry Industry Veterinary Biological Vaccines Product Overview
9.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Product Market Performance
9.25.4 China Animal Husbandry Industry Business Overview
9.25.5 China Animal Husbandry Industry Recent Developments
9.26 Wuhan Keqian Biology
9.26.1 Wuhan Keqian Biology Veterinary Biological Vaccines Basic Information
9.26.2 Wuhan Keqian Biology Veterinary Biological Vaccines Product Overview
9.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Product Market Performance
9.26.4 Wuhan Keqian Biology Business Overview
9.26.5 Wuhan Keqian Biology Recent Developments
9.27 Pulike Biological Engineering
9.27.1 Pulike Biological Engineering Veterinary Biological Vaccines Basic Information
9.27.2 Pulike Biological Engineering Veterinary Biological Vaccines Product Overview
9.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Product Market Performance
9.27.4 Pulike Biological Engineering Business Overview
9.27.5 Pulike Biological Engineering Recent Developments
9.28 Chengdu Kanghua Biological Products
9.28.1 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Basic Information
9.28.2 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Overview
9.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Market Performance
9.28.4 Chengdu Kanghua Biological Products Business Overview
9.28.5 Chengdu Kanghua Biological Products Recent Developments
10 Veterinary Biological Vaccines Market Forecast by Region
10.1 Global Veterinary Biological Vaccines Market Size Forecast
10.2 Global Veterinary Biological Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Veterinary Biological Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Veterinary Biological Vaccines Market Size Forecast by Region
10.2.4 South America Veterinary Biological Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Veterinary Biological Vaccines by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Veterinary Biological Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Veterinary Biological Vaccines by Type (2025-2030)
11.1.2 Global Veterinary Biological Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Veterinary Biological Vaccines by Type (2025-2030)
11.2 Global Veterinary Biological Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Veterinary Biological Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Veterinary Biological Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings